Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ilkka Liikanen, Anniina Koski, Maiju Merisalo-Soikkeli, Otto Hemminki, Minna Oksanen, Kalevi Kairemo, Timo Joensuu, Anna Kanerva & Akseli Hemminki. (2015) Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy. OncoImmunology 4:3.
Read now
Read now
Articles from other publishers (34)
Yutaro Inada, Motoshi Sonoda, Yumi Mizuno, Kenichiro Yamamura, Yoshitomo Motomura, Aoba Takuma, Kenji Murata, Kenji Furuno, Junichiro Tezuka, Yasunari Sakai, Shouichi Ohga, Junji Kishimoto, Koki Hosaka, Satomi Sakata & Toshiro Hara. (2023)
CD14
down‐modulation as a real‐time biomarker in Kawasaki disease
. Clinical & Translational Immunology 13:1.
Crossref
Crossref
Wenyi Yang, Pingping Wang, Meng Luo, Yideng Cai, Chang Xu, Guangfu Xue, Xiyun Jin, Rui Cheng, Jinhao Que, Fenglan Pang, Yuexin Yang, Huan Nie, Qinghua Jiang, Zhigang Liu & Zhaochun Xu. (2023) DeepCCI: a deep learning framework for identifying cell–cell interactions from single-cell RNA sequencing data. Bioinformatics 39:10.
Crossref
Crossref
Dae Chul Jeong. (2023) Kawasaki Disease and Innate Immunity. Kawasaki Disease 1:1.
Crossref
Crossref
Abbas Shahi, Shima Afzali, Zahra Firoozi, Poopak Mohaghegh, Ali Moravej, Ali Hosseinipour, Maryam Bahmanyar & Yaser Mansoori. (2023) Potential roles of NLRP3 inflammasome in the pathogenesis of Kawasaki disease. Journal of Cellular Physiology 238:3, pages 513-532.
Crossref
Crossref
Seigo Okada, Hiroki Yasudo, Yuji Ohnishi, Chie Matsuguma, Reiji Fukano, Takahiro Motonaga, Takako Waniishi & Shunji Hasegawa. (2022) Interleukin-33/ST2 Axis as Potential Biomarker and Therapeutic Target in Kawasaki Disease. Inflammation 46:1, pages 480-490.
Crossref
Crossref
Souad Belmadani & Khalid Matrougui. (2022) Role of High Mobility Group Box 1 in Cardiovascular Diseases. Inflammation 45:5, pages 1864-1874.
Crossref
Crossref
Laura Petrarca, Valeria Manganelli, Raffaella Nenna, Antonella Frassanito, Shira Ben David, Enrica Mancino, Tina Garofalo, Maurizio Sorice, Roberta Misasi & Fabio Midulla. (2022) HMGB1 in Pediatric COVID-19 Infection and MIS-C: A Pilot Study. Frontiers in Pediatrics 10.
Crossref
Crossref
Yuanji Dong, Bingxia Ming & Lingli Dong. (2022) The Role of HMGB1 in Rheumatic Diseases. Frontiers in Immunology 13.
Crossref
Crossref
Imaniar Noor Faridah, Dyah Aryani Perwitasari & Wei-Chiao Chang. 2022. Kawasaki Disease. Kawasaki Disease
103
116
.
Kenji Murata, Sagano Onoyama, Kenichiro Yamamura, Yumi Mizuno, Kenji Furuno, Keita Matsubara, Ken Hatae, Kiminori Masuda, Yuichi Nomura, Takuro Ohno, Akiko Kinumaki, Masaru Miura, Yasunari Sakai, Shouichi Ohga, Wakaba Fukushima, Junji Kishimoto, Yosikazu Nakamura & Toshiro Hara. (2021) Kawasaki Disease and Vaccination: Prospective Case-Control and Case-Crossover Studies among Infants in Japan. Vaccines 9:8, pages 839.
Crossref
Crossref
Kaushal Sharma, Pandiarajan Vignesh, Priyanka Srivastava, Jyoti Sharma, Himanshi Chaudhary, Sanjib Mondal, Anupriya Kaur, Harvinder Kaur & Surjit Singh. (2021) Epigenetics in Kawasaki Disease. Frontiers in Pediatrics 9.
Crossref
Crossref
Takashi Inoue, Shokei Murakami & Akio Matsuda. (2021) Frontiers of Kawasaki disease research川崎病研究の最前線. Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology 35:2, pages 145-151.
Crossref
Crossref
Shinichiro Morichi, Gaku Yamanaka, Yusuke Watanabe, Tomoko Takamatsu, Akiko Kasuga, Mika Takeshita, Soken Go, Yu Ishida, Shingo Oana, Yasuyo Kashiwagi & Hisashi Kawashima. (2021) High mobility group box 1 and angiogenetic growth factor levels in children with central nerve system infections. Journal of Infection and Chemotherapy 27:6, pages 840-844.
Crossref
Crossref
Kentaro Ueno, Yuichi Nomura, Yasuko Morita & Yoshifumi Kawano. (2021) Prednisolone Suppresses the Extracellular Release of HMGB-1 and Associated Inflammatory Pathways in Kawasaki Disease. Frontiers in Immunology 12.
Crossref
Crossref
Bo Li, Xin Peng, He Li, Fei Chen, Yuxia Chen, Yingqian Zhang & Kai Le. (2020) The performance of the alarmin HMGB1 in pediatric diseases: From lab to clinic. Immunity, Inflammation and Disease 9:1, pages 8-30.
Crossref
Crossref
Toshiro Hara, Kenichiro Yamamura & Yasunari Sakai. (2021) The up‐to‐date pathophysiology of Kawasaki disease. Clinical & Translational Immunology 10:5.
Crossref
Crossref
Biying Qian, Hua Huang, Mingye Cheng, Tingting Qin, Tao Chen & Jianmei Zhao. (2020) Mechanism of HMGB1–RAGE in Kawasaki disease with coronary artery injury. European Journal of Medical Research 25:1.
Crossref
Crossref
Takashi Inoue, Shokei Murakami, Kenji Matsumoto & Akio Matsuda. (2020) Functional benefits of corticosteroid and IVIG combination therapy in a coronary artery endothelial cell model of Kawasaki disease. Pediatric Rheumatology 18:1.
Crossref
Crossref
Rajni Kumrah, Pandiarajan Vignesh, Amit Rawat & Surjit Singh. (2020) Immunogenetics of Kawasaki disease. Clinical Reviews in Allergy & Immunology 59:1, pages 122-139.
Crossref
Crossref
Seigo Okada, Shintaro Hashimoto, Akiko Miyake, Yusuke Okada, Reiji Hirano, Shinnosuke Fukunaga & Yuichi Ishikawa. (2020) Kawasaki Disease Following Severe Sunburn Injury. Frontiers in Pediatrics 8.
Crossref
Crossref
Chang Jia, Jian Zhang, Huanwen Chen, Yingzhi Zhuge, Huiqiao Chen, Fanyu Qian, Kailiang Zhou, Chao Niu, Fangyan Wang, Huixian Qiu, Zhenquan Wang, Jian Xiao, Xing Rong & Maoping Chu. (2019) Endothelial cell pyroptosis plays an important role in Kawasaki disease via HMGB1/RAGE/cathespin B signaling pathway and NLRP3 inflammasome activation. Cell Death & Disease 10:10.
Crossref
Crossref
Jong Gyun Ahn, Yoonsun Bae, Dongjik Shin, Jiho Nam, Kyu Yeun Kim & Dong Soo Kim. (2019) HMGB1 gene polymorphism is associated with coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease. Rheumatology 58:5, pages 770-775.
Crossref
Crossref
Bin ZhuNanfang LiQing ZhuTing WuMulalibieke HeizatiGuoliang WangXiaoguang YaoQin LuoShasha LiuShanshan LiuJing Hong. (2019) Association of serum high mobility group box 1 levels with disease activity and renal involvement in patients with systemic vasculitis. Medicine 98:6, pages e14493.
Crossref
Crossref
T Hara, Y Nakashima, Y Sakai, H Nishio, Y Motomura & S Yamasaki. (2016) Kawasaki disease: a matter of innate immunity. Clinical and Experimental Immunology 186:2, pages 134-143.
Crossref
Crossref
Norma Maugeri, Patrizia Rovere-Querini & Angelo A. Manfredi. (2016) Disruption of a Regulatory Network Consisting of Neutrophils and Platelets Fosters Persisting Inflammation in Rheumatic Diseases. Frontiers in Immunology 7.
Crossref
Crossref
Alexandre W. S. de Souza, Kornelis S. M. van der Geest, Elisabeth Brouwer, Frederico A. G. Pinheiro, Ana Cecília Diniz Oliveira, Emília Inoue Sato, Luis Eduardo C. Andrade, Marc Bijl, Johanna Westra & Cees G. M. Kallenberg. (2015) High mobility group box 1 levels in large vessel vasculitis are not associated with disease activity but are influenced by age and statins. Arthritis Research & Therapy 17:1.
Crossref
Crossref
Chen Wang, Alexandre W.S. de Souza, Johanna Westra, Marc Bijl, Min Chen, Ming-Hui Zhao & Cees G.M. Kallenberg. (2015) Emerging role of high mobility group box 1 in ANCA-associated vasculitis. Autoimmunity Reviews 14:11, pages 1057-1065.
Crossref
Crossref
Rui Kang, Ruochan Chen, Qiuhong Zhang, Wen Hou, Sha Wu, Lizhi Cao, Jin Huang, Yan Yu, Xue-gong Fan, Zhengwen Yan, Xiaofang Sun, Haichao Wang, Qingde Wang, Allan Tsung, Timothy R. Billiar, Herbert J. ZehIIIIII, Michael T. Lotze & Daolin Tang. (2014) HMGB1 in health and disease. Molecular Aspects of Medicine 40, pages 1-116.
Crossref
Crossref
Valeria Chirico, Antonio Lacquaniti, Vincenzo Salpietro, Caterina Munafò, Maria Pia Calabrò, Michele Buemi, Teresa Arrigo & Carmelo Salpietro. (2014) High-mobility group box 1 (HMGB1) in childhood: from bench to bedside. European Journal of Pediatrics 173:9, pages 1123-1136.
Crossref
Crossref
G A Ramirez, N Maugeri, M G Sabbadini, P Rovere-Querini & A A Manfredi. (2014) Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum. Clinical and Experimental Immunology 175:2, pages 150-166.
Crossref
Crossref
Sonal Mehra & Marvin J. Fritzler. (2014) The Spectrum of Anti-Chromatin/Nucleosome Autoantibodies: Independent and Interdependent Biomarkers of Disease. Journal of Immunology Research 2014, pages 1-15.
Crossref
Crossref
Toshiaki Nakano, Chao-Long Chen & Shigeru Goto. (2013) Nuclear Antigens and Auto/Alloantibody Responses: Friend or Foe in Transplant Immunology. Clinical and Developmental Immunology 2013, pages 1-9.
Crossref
Crossref
A.W.S. de Souza, J. Westra, P.C. Limburg, M. Bijl & C.G.M. Kallenberg. (2012) HMGB1 in vascular diseases: Its role in vascular inflammation and atherosclerosis. Autoimmunity Reviews 11:12, pages 909-917.
Crossref
Crossref
Helena Erlandsson Harris, Ulf Andersson & David S. Pisetsky. (2012) HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease. Nature Reviews Rheumatology 8:4, pages 195-202.
Crossref
Crossref